key: cord-0022507-47fkc067 authors: Rankin, Brian D.; Haber, Richard M. title: Familial granuloma annulare: First report of occurrence in a father and daughter and updated review of the literature date: 2021-10-02 journal: JAAD Case Rep DOI: 10.1016/j.jdcr.2021.09.023 sha: 4bb46e76ee95036d9e4ab9c94c8c4da3c0c442da doc_id: 22507 cord_uid: 47fkc067 nan Granuloma annulare (GA) is a common, benign, often self-limiting granulomatous disease. The condition classically presents clinically with asymptomatic, flesh-colored to erythematous, nonscaling papules, often arranged in a ring or annular pattern. Histologically, GA is characterized by a perivascular lymphocytic infiltrate, the accumulation of macrophages in the dermis, and palisading of the macrophages around degenerated areas with altered collagen. A delayed-type cell-mediated hypersensitivity reaction is the favored hypothesis; however, the etiology and pathogenesis of GA is not fully understood. It has been associated with various systemic diseases, including diabetes mellitus and dyslipidemia, and has also been reported to develop after exposure to assorted triggers, often cutaneous trauma. 1 Although uncommon, familial occurrences of GA have also been reported. Friedman and Winkelmann 2 last reviewed familial GA in 1987, describing 11 families and 21 cases of GA with at least 2 immediate family members affected. These authors also suggested that the incidence of specific human leukocyte antigens (HLAs) (eg, HLA-B35) within some of these family members might indicate that genetically predisposed individuals could develop a cell-mediated immune reaction in response to an unknown antigen. In this report, we describe the cases of 2 patients, a father and his daughter, who presented with clinical and histologically confirmed GA. We also review all familial occurrences of GA since 1987. A 68-year-old man presented with asymptomatic annular lesions on his right forearm 9 years previously. These failed to respond to topical steroids and antifungal creams. He had 2 children; 1 daughter who also has GA (described below) and 1 unaffected son. He was on no oral medications and had no history of diabetes mellitus or hyperlipidemia. Physical examination revealed a 5-cm erythematous annular plaque on the dorsum of his left hand and 2 erythematous 4-cm plaques on his right forearm; 1 annular and 1 arcuate (Fig 1) . A punch biopsy from the annular plaque on his right forearm was read by a dermatopathologist as GA. As his lesions were asymptomatic, he declined treatment. His HLA genotype study showed expression of HLA-B35. A 41-year-old woman and daughter of case 1, had a history of asymptomatic annular lesions that started on the right hand 4 years previously but then developed on her ankle, calf, and forearms. She was on no medications and had no history of diabetes mellitus or hyperlipidemia but did have a history of idiopathic uveitis. She has 2 children, both without similar skin lesions. Physical examination Abbreviations used: GA: granuloma annulare HLA: human leukocyte antigen TNF-a: tumor necrosis factor-alfa revealed multiple approximately 2-cm annular plaques on her right hand and forearm, a 4-cm erythematous annular plaque on her right wrist (Fig 2) , and a 4-cm annular plaque on her right calf. A punch biopsy from the annular plaque on her right leg showed an interstitial histiocytic infiltrate that palisaded around zones of collagen necrobiosis. Colloidal iron showed focal staining within the necrobiotic zones and the features were consistent with GA. She wished to have treatment for the GA, and several of the plaques have been treated with intralesional triamcinolone acetonide over the years with a good result. HLA genotyping showed expression of HLA-B35 and B27. Friedman and Winkelmann 2 provided the last detailed review of the literature on familial GA in 1987. The purpose of our report is to add, to our knowledge, the first cases of GA in a father and daughter, and update the literature of all reported cases of familial GA since 1987. An additional 7 reports of GA involving at least 2 immediate family members have appeared in the literature since 1987 (Table I) . [3] [4] [5] [6] [7] [8] [9] With these new additions, there are now 6 reports of GA occurring in successive generations, 12 reports of GA occurring in siblings, 5 reports of GA in monozygotic twins, and 1 report of GA in dizygotic twins in the literature. A variety of GA subtypes have been reported within this group, including localized, subcutaneous, generalized, and perforating. None of the newly reported patients were diabetic. Distinct HLA associations have been reported in some patients with GA, especially an increased prevalence of HLA-B35 in patients with generalized GA but not in localized GA, and this association has been used to suggest a genetic predisposition to GA. 2,10 HLA genotyping confirmed that both our patients also expressed HLA-B35 even though the father had localized GA and the daughter generalized GA. This is similar to Friedman and Winkelmann's 2 report on 2 sisters who both were determined to have HLA-B35 with the older sister having generalized GA and the younger sister, localized GA. The finding of HLA-B35 in both reports of familial GA cases adds further evidence to the association of HLA-B35 in patients with familial GA. Only 1 of the other 7 newly reviewed reports of familial GA provided HLA genotyping results. 7 In that report of 2 monozygotic twin sisters, both had human ancestral haplotype 8.1, a genotype that has been associated with a tumor necrosis factor-alfa (TNF-a) polymorphism leading to production of TNF-a by peripheral blood mononuclear cells. As both sisters responded to a trial of adalimumab, it was speculated that patients with GA with TNF-a polymorphisms are more likely to respond to TNF-a blocking agents. There are currently no standardized guidelines on the management of GA. Common treatments include dapsone, tetracyclines, fumaric acid esters, retinoids, antimalarials, cyclosporine, methotrexate, TNF-a inhibitors, phototherapy, lasers, and photodynamic therapy. In our cases, 1 patient declined treatment, whereas the other responded well to intralesional triamcinolone acetonide. Without a clear etiology and given the paucity of reported familial incidences of GA, there remains the possibility that the patients' clinical presentations and familial relationship are a chance observation. The only strong genetic predisposition appears to be an increased prevalence of HLA-B35 in patients with generalized GA although HLA-B35 has now been found in 2 families with both localized and generalized familial GA patients. We encourage further reports of familial GA to elucidate their incidence and more detailed genetic assessment in cases that do demonstrate a familial association. Granuloma annulare: pathogenesis, disease associations and triggers, and therapeutic options Report of two cases and review of the literature Familial generalized perforating granuloma annulare Familial granuloma annulare Localized granuloma annulare in children: a review of 42 cases Granuloma annulare in the hand Efficacy of adalimumab in the treatment of generalized granuloma annulare in monozygotic twins carrying the 8.1 ancestral haplotype Familial granuloma annulare. Article in Turkish Granuloma annulare and SARS-CoV-2 pandemic A study of HLA antigen association in localized and generalized granuloma annulare None disclosed.